13F

PTCT PTC THERAPEUTICS INC

2026Q1 · CUSIP 69366J200 · Sector: Healthcare & Biotech

Cooling · Breadth rolling over
Holders
349
Δ holders QoQ
-1
Breadth percentile
Top 66%
Whale holders
164
Δ whales
-2
Inst. holding value
$6.5B
New positions
61
Closed positions
62
Price momentum (1Q)
+1.4%
Put / Call
4/6

Breadth history (34 quarters)

2018Q1: Δ+24 · h=148 2018Q2: Δ+18 · h=166 2018Q3: Δ+16 · h=182 2018Q4: Δ-16 · h=166 2019Q1: Δ+9 · h=175 2019Q2: Δ+0 · h=175 2019Q3: Δ+9 · h=184 2019Q4: Δ+23 · h=207 2020Q1: Δ-6 · h=201 2020Q2: Δ+2 · h=203 2020Q3: Δ-5 · h=198 2020Q4: Δ+20 · h=218 2021Q1: Δ-8 · h=210 2021Q2: Δ-26 · h=184 2021Q3: Δ-1 · h=183 2021Q4: Δ-5 · h=178 2022Q1: Δ+6 · h=184 2022Q2: Δ-3 · h=181 2022Q3: Δ+30 · h=211 2022Q4: Δ-6 · h=205 2023Q1: Δ-3 · h=202 2023Q2: Δ+4 · h=206 2023Q3: Δ-26 · h=180 2023Q4: Δ-7 · h=173 2024Q1: Δ+10 · h=183 2024Q2: Δ+16 · h=199 2024Q3: Δ+4 · h=203 2024Q4: Δ+40 · h=243 2025Q1: Δ+19 · h=262 2025Q2: Δ+23 · h=285 2025Q3: Δ+12 · h=297 2025Q4: Δ+53 · h=350 2026Q1: Δ-1 · h=349 2018Q1: holders=148 2018Q2: holders=166 2018Q3: holders=182 2018Q4: holders=166 2019Q1: holders=175 2019Q2: holders=175 2019Q3: holders=184 2019Q4: holders=207 2020Q1: holders=201 2020Q2: holders=203 2020Q3: holders=198 2020Q4: holders=218 2021Q1: holders=210 2021Q2: holders=184 2021Q3: holders=183 2021Q4: holders=178 2022Q1: holders=184 2022Q2: holders=181 2022Q3: holders=211 2022Q4: holders=205 2023Q1: holders=202 2023Q2: holders=206 2023Q3: holders=180 2023Q4: holders=173 2024Q1: holders=183 2024Q2: holders=199 2024Q3: holders=203 2024Q4: holders=243 2025Q1: holders=262 2025Q2: holders=285 2025Q3: holders=297 2025Q4: holders=350 2026Q1: holders=349 -53 -26.5 +0 +26.5 +53 133251368 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 10 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 9% +1.4%
2025Q2 Top 13% +51.2% +38.4%
2025Q1 Top 12% +5.6% +61.0%
2024Q4 Top 13% -5.0% +0.3%
2024Q2 Top 17% +26.8% +50.9%
2022Q3 Top 3% +24.8% +56.1%
2019Q4 Top 19% -14.9% -13.6%
2018Q3 Top 14% -7.5% +19.1%
2018Q2 Top 13% -25.7% -30.2%
2018Q1 Top 7% +35.4% +0.5%

Options Sentiment

Put holders
4
QoQ: -2
Call holders
6
QoQ: -1

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-2.29
EPS YoY
-135.2%
Revenue (TTM)
$0.8B
Revenue YoY
-53.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0.2B 2022-09-30: $0.2B 2022-12-31: $0.2B 2023-03-31: $0.2B 2023-06-30: $0.2B 2023-09-30: $0.2B 2023-12-31: $0.3B 2024-03-31: $0.2B 2024-06-30: $0.2B 2024-09-30: $0.2B 2024-12-31: $0.2B 2025-03-31: $1.2B 2025-06-30: $0.2B 2025-09-30: $0.2B 2025-12-31: $0.2B 2026-03-31: $0.3B 2022-06-30: EPS -2.13 2022-09-30: EPS -1.53 2022-12-31: EPS -2.35 2023-03-31: EPS -1.88 2023-06-30: EPS -2.66 2023-09-30: EPS -1.76 2023-12-31: EPS -2.07 2024-03-31: EPS -1.20 2024-06-30: EPS -1.29 2024-09-30: EPS -1.39 2024-12-31: EPS -0.85 2025-03-31: EPS 10.04 2025-06-30: EPS -0.83 2025-09-30: EPS 0.20 2025-12-31: EPS -1.63 2026-03-31: EPS -0.03 0B 0.6B 1.2B $B -2.93 4.06 11.04 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 9 2025-03-31: PE 7.12025-06-30: PE 72025-09-30: PE 8.82025-12-31: PE 8.9 6 8 9 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)